Literature DB >> 34652060

The novel and recurrent variants in exon 31 of CREBBP in Japanese patients with Menke-Hennekam syndrome.

Eriko Nishi1, Toshiki Takenouchi2, Fuyuki Miya3, Tomoko Uehara2, Kumiko Yanagi4, Yuiko Hasegawa1, Kimiko Ueda1, Seiji Mizuno5, Tadashi Kaname4, Kenjiro Kosaki2, Nobuhiko Okamoto1.   

Abstract

Menke-Hennekam syndrome-1 (MKHK1) is a congenital disorder caused by the heterozygous variants in exon 30 or 31 of CREBBP (CREB binding protein) gene mapped on 16p13.3. It is characterized by psychomotor delay, variable impairment of intellectual disability (ID), feeding difficulty, autistic behavior, hearing impairment, short stature, microcephaly, and facial dysmorphisms. The CREBBP loss-of-function variants cause Rubinstein-Taybi syndrome-1 (RSTS1). The function of CREBBP leading to MKHK1 has not been clarified so far, and the phenotype of MKHK1 significantly differs from that of RSTS1. We examined six patients with de novo pathogenic variants affecting the last exon of CREBBP, and they shared the clinical features of MKHK1. This study revealed that one frameshift and three nonsense variants of CREBBP cause MKHK1, and inferred that the nonsense variants of the last exon could further help in the elucidation of the etiology of MKHK1.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  CREBBP; Menke-Hennekam syndrome; Rubinstein-Taybi syndrome; exon 31

Mesh:

Substances:

Year:  2021        PMID: 34652060     DOI: 10.1002/ajmg.a.62533

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Menke-Hennekam Syndrome: A Literature Review and a New Case Report.

Authors:  Aurora Sima; Roxana Elena Smădeanu; Anca Angela Simionescu; Florina Nedelea; Andreea-Maria Vlad; Cristina Becheanu
Journal:  Children (Basel)       Date:  2022-05-22

2.  TTC5 syndrome: Clinical and molecular spectrum of a severe and recognizable condition.

Authors:  Luciana Musante; Flavio Faletra; Kolja Meier; Hoda Tomoum; Paria Najarzadeh Torbati; Edward Blair; Sally North; Jutta Gärtner; Susann Diegmann; Mehran Beiraghi Toosi; Farah Ashrafzadeh; Ehsan Ghayoor Karimiani; David Murphy; Flora Maria Murru; Caterina Zanus; Andrea Magnolato; Martina La Bianca; Agnese Feresin; Giorgia Girotto; Paolo Gasparini; Paola Costa; Marco Carrozzi
Journal:  Am J Med Genet A       Date:  2022-06-07       Impact factor: 2.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.